S&P Futures
5,904.25 -1.75 (-0.03%) Dow Futures
43,537.00 +19.00 (+0.04%) Nasdaq Futures
20,461.75 -21.75 (-0.11%) Russell 2000 Futures
2,292.70 +1.50 (+0.07%) Crude Oil
69.67 +0.45 (+0.65%) Gold
2,742.60 +12.60 (+0.46%)
Bioxytran, Inc. (BIXT)
| Previous Close | 0.0000 |
| Open | 0.1060 |
| Bid | 0.1050 x 0 |
| Ask | 0.1100 x 0 |
| Day's Range | 0.1060 - 0.1120 |
| 52 Week Range | 0.0710 - 0.1866 |
| Volume | |
| Avg. Volume | 54,542 |
| Market Cap | 9.004M |
| Beta (5Y Monthly) | -0.87 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.0200 |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
GlobeNewswirePresenting on the Emerging Growth Conference 75 Day 2 on September 26
MIAMI, Sept. 25, 2024 (GLOBE NEWSWIRE) -- EmergingGrowth.com, a leading independent small cap media portal, announces the schedule of the 75th Emerging Growth Conference on September 25 & 26, 2024. The Emerging Growth Conference identifies companies in a wide range of growth sectors, with strong management teams, innovative products & services, focused strategy, execution, and the overall potential for long-term growth. Register for the Conference here. Submit Questions for any of the presenting
ACCESSWIREBioxytran's Medical Breakthrough in Fighting All Viruses
Breakthrough was validated in the latest journal article Galectins are essential for viral entry and a new target for drug development Carbohydrates were shown to neutralize viruses Blocking galectins could be the most efficient way to prevent and ...
